Damage to particular regions of the brain may influence addiction behaviors, providing insight into potential therapeutic targets for substance use disorders.
John Csernansky, MD, former chair and Lizzie Gilman Professor of Psychiatry and Behavioral Sciences, whose career at Northwestern spanned nearly 15 years, passed away recently at age 68.
Children born to women who took antipsychotic medications later in their pregnancy did not show increased risk of neurodevelopmental disorders, according to a recent study.
Sara Becker, PhD, of the Brown University School of Public Health and the Warren Alpert Medical School, has been named the Alice Hamilton Professor of Psychiatry and inaugural director of the newly formed Center for Dissemination and Implementation Science, which is part of the Institute for Public Health and Medicine, effective August 1st.
A biomarker in the brain predicts future cognitive decline in patients with the language form of Alzheimer’s disease (AD), reports a new Northwestern Medicine study.
Sachin Patel, MD, PhD, has been named chair and Lizzie Gilman Professor of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine, and psychiatrist-in-chief at Northwestern Memorial Hospital’s Norman and Ida Stone Institute of Psychiatry.
Northwestern Medicine scientists have discovered an unexpected connection between a protein implicated in neuropsychiatric disorders and the endocannabinoid pathway.
A mental health smartphone app developed by a team of Northwestern Medicine investigators helped improve depressive symptoms in patients with diabetes and hypertension, according to a recent clinical trial published in JAMA.
Alterations in the balance of two chloride transporters may be responsible for cognitive deficits in schizophrenia, according to a Northwestern Medicine study.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.